Type I Interferon Receptors: Biochemistry and Biological Functions*

The type I interferon (IFN)2 receptor (IFNAR) is comprised, as other cytokine receptors, of multiple components, in this case designated IFNAR1 and IFNAR2. However it is unique among cytokine receptors in the number of cognate ligands, including 13 IFN subtypes, , , , , and others in some species. The type I IFN receptors are distinct from those required for the type II IFN (IFNGR1 and IFNGR2) and type III IFNs (IFNLR and IL10R ). Nevertheless, genes encoding a component of each type of IFN receptor, namely IFNAR1, IFNAR2, IFNGR2, and IL10R , are located on human chromosome 21q22.1 in a cytokine receptor gene cluster, as typical of functionally related genes. Although IFNswere identified 50 years ago and the existence of IFN receptors 10 years later, it was in 1990when the first type I IFN receptor, now designated IFNAR1, was cloned. This was achieved utilizing human gene libraries expressed in murine cells and rescue of the definitive, species specific antiviral activity of human IFN 8 (1). IFNAR2 cloning was achieved first by identifying a human IFN binding activity in urine, peptide sequencing, and then by gene library screening with derived oligonucleotides (2). It was subsequently discovered that the original cDNA encoded only one isoform of the IFNAR2 gene, which also encoded a long transmembrane isoform that transduced a signal, a truncated transmembrane isoform, and a soluble/secreted isoform (3) (Fig. 1A). Subsequently, the functions of the type I IFN receptors have been elucidated with respect to ligand interaction, mechanisms of signal transduction, and biological responses. The pioneering studies that discovered IFNARs and their mechanisms of actions in vitro have been largely validated in vivo using genetargetedmice. This body of work has highlighted the important roles of IFNARs inmediating type I IFN responses in hemopoiesis and innate and acquired immunity to infection and cancer. However, IFNs elicit many biological effects that can even be opposite in different cell types. For example, type I IFN inhibits proliferation and is proapoptotic for many cell types (4), yet it prolongs the survival of memory T cells (5). Understanding the function of the IFNAR complexwill elucidate how such a diversity of biological outcomes is generated.

[1]  S. Lata,et al.  Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. , 2004, Journal of molecular biology.

[2]  A. Whitty,et al.  Systematic mutational mapping of sites on human interferon-beta-1a that are important for receptor binding and functional activity. , 2000, Biochemistry.

[3]  G. Stark,et al.  Mutant U5A cells are complemented by an interferon‐alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. , 1995, The EMBO journal.

[4]  S. Fuchs,et al.  TYK2 activity promotes ligand-induced IFNAR1 proteolysis. , 2006, The Biochemical journal.

[5]  E. Fish,et al.  Evidence for glycosphingolipid modification of the type 1 IFN receptor. , 1994, Journal of immunology.

[6]  M. Tymms,et al.  A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Rose-John,et al.  The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. , 2002, Biochimica et biophysica acta.

[8]  I. Kola,et al.  The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties. , 2001, Blood.

[9]  R. Levy,et al.  The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding. , 2003, Structure.

[10]  L. Platanias Mechanisms of type-I- and type-II-interferon-mediated signalling , 2005, Nature Reviews Immunology.

[11]  Differential Responsiveness of a Splice Variant of the Human Type I Interferon Receptor to Interferons* , 1996, The Journal of Biological Chemistry.

[12]  A. Alcamí,et al.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.

[13]  M. Saraste,et al.  FEBS Lett , 2000 .

[14]  G Schreiber,et al.  Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2. , 1999, Journal of molecular biology.

[15]  J. Sprent,et al.  Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha}. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Fernandez-Botran Soluble cytokine receptors: their role in immunoregulation , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  P. Hertzog,et al.  Characterization and transcriptional analysis of the mouse Chromosome 16 cytokine receptor gene cluster , 2003, Mammalian Genome.

[18]  G. Lutfalla,et al.  Genetic transfer of a functional human interferon α receptor into mouse cells: Cloning and expression of its c-DNA , 1990, Cell.

[19]  Fuencisla Matesanz,et al.  IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response , 2005, Journal of Neuroimmunology.

[20]  I. Kola,et al.  Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome. , 1997, Human molecular genetics.

[21]  P. Hertzog,et al.  Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression. , 2002, The Biochemical journal.

[22]  W. Windsor,et al.  Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor , 1995, Nature.

[23]  X. Gallet,et al.  Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity. , 2004, Biochemistry.

[24]  J. Krolewski,et al.  Regulated proteolysis of the IFNaR2 subunit of the interferon-alpha receptor , 2004, Oncogene.

[25]  N. Cordani,et al.  The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells. , 2005, International journal of oncology.

[26]  S. Constantinescu,et al.  Direct Association of STAT3 with the IFNAR-1 Chain of the Human Type I Interferon Receptor (*) , 1996, The Journal of Biological Chemistry.

[27]  I. Kola,et al.  Cloning and Characterization of Soluble and Transmembrane Isoforms of a Novel Component of the Murine Type I Interferon Receptor, IFNAR 2* , 1997, The Journal of Biological Chemistry.

[28]  J. Krolewski,et al.  Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction , 1996, Molecular and cellular biology.

[29]  L. Platanias,et al.  A Region of the β Subunit of the Interferon α Receptor Different from Box 1 Interacts with Jak1 and Is Sufficient to Activate the Jak-Stat Pathway and Induce an Antiviral State* , 1997, The Journal of Biological Chemistry.

[30]  P. Eid,et al.  Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons. , 2000, European cytokine network.

[31]  J. Sprent,et al.  Stimulation of naive and memory T cells by cytokines , 1999, Immunological reviews.

[32]  D. Novick,et al.  Soluble interferon‐α receptor molecules are present in body fluids , 1992 .

[33]  D. Stuart,et al.  Crystal structure of the extracellular region of human tissue factor , 1994, Nature.

[34]  R. Roberts,et al.  Antiviral activities of the soluble extracellular domains of type I interferon receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  P. Sperryn,et al.  Blood. , 1989, British journal of sports medicine.

[36]  M. Lathrop,et al.  Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. , 2006, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[37]  V. Nguyễn,et al.  Stat2 Binding to the Interferon-α Receptor 2 Subunit Is Not Required for Interferon-α Signaling* , 2002, The Journal of Biological Chemistry.

[38]  J. Scheller,et al.  IL-6 transsignaling: the in vivo consequences. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[39]  R. Rosenfeld Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[40]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  F. Young Biochemistry , 1955, The Indian Medical Gazette.

[42]  M. Muraguchi,et al.  Serum levels of soluble interferon alfa/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C , 1999, Hepatology.

[43]  B. Cohen,et al.  Ligand-induced association of the type I interferon receptor components , 1995, Molecular and cellular biology.

[44]  A. Brass,et al.  Gene expression profiling in a mouse model for African trypanosomiasis , 2006, Genes and Immunity.

[45]  E. Ratovitski,et al.  Identification of mRNAs encoding two different soluble forms of the human interferon α‐receptor , 1994 .

[46]  K. Shuai,et al.  UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity , 2006, The EMBO journal.

[47]  S. Fuchs,et al.  Phosphorylation and Specific Ubiquitin Acceptor Sites Are Required for Ubiquitination and Degradation of the IFNAR1 Subunit of Type I Interferon Receptor* , 2004, Journal of Biological Chemistry.

[48]  A. Arulanandam,et al.  Formation of human IFN-beta complex with the soluble type I interferon receptor IFNAR-2 leads to enhanced IFN stability, pharmacokinetics, and antitumor activity in xenografted SCID mice. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[49]  D. Kwiatkowski,et al.  Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in The Gambia , 2003, Genes and Immunity.

[50]  J. van der Heyden,et al.  Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1. , 2005, Journal of molecular biology.

[51]  G. Lutfalla,et al.  α and α Interferons and Their Receptor and Their Friends and Relations , 1995 .

[52]  H. Whittle,et al.  Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[54]  M. Gavutis,et al.  Differential receptor subunit affinities of type I interferons govern differential signal activation. , 2007, Journal of molecular biology.

[55]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[56]  K. Inageda,et al.  Genetic variations in humans associated with differences in the course of hepatitis C. , 2004, Biochemical and biophysical research communications.

[57]  B. Cohen,et al.  The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.

[58]  D. Sykes,et al.  Free interferon‐α/β receptors in the circulation of patients with adenocarcinoma , 2003 .

[59]  G. Feng,et al.  Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway , 1999, Molecular and Cellular Biology.

[60]  Paul J Hertzog,et al.  Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity , 2006, Nature Immunology.

[61]  G. Stark,et al.  Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling , 1997, Molecular and cellular biology.